Insider Transactions Reported | Hims & Hers Health(HIMS)saw insider trading activity on 7/25/2025
ByAinvest
Saturday, Jul 26, 2025 12:00 am ET1min read
HIMS--
Hims & Hers Health(HIMS) saw insider trading activity on 7/25/2025, there were 6 insider trades during the day.
【History Insider Transaction】
| Declare date | Position | Name | Buy/Sell | Quantity | Price per share/USD | Total Amount/USD |
|---|---|---|---|---|---|---|
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 900 | 6.82 | 6.14k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 14700 | 5.01 | 73.65k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Sell | 13750 | 56.00 | 770.0k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Sell | 2100 | 57.52 | 120.79k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 250 | 11.53 | 2.88k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 41667 | 49.56 | 2064.85k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 50000 | 49.60 | 2479.94k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Buy | 125335 | 2.43 | 304.56k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 17001 | 49.43 | 840.28k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 16667 | 49.41 | 823.58k |
[Company Profile]
Hims & Hers Health, Inc. was established as a Delaware company on December 30, 2013. Their mission is to enable everyone to enjoy affordable and convenient healthcare. They designed and built cloud-based digital native technology with consumers as the center, and considered consumers in the design. Their proprietary website, telemedicine platform, electronic medical record system, pharmacy integration and mobile accessibility combine to provide consumers with a seamless, easy-to-use, mobile-first experience.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet